BHP Billiton PLC (LON:BLT) Stock Rating Maintained by HSBC; The GBX 1870.00 Target Indicates 14.70% Potential; Shorts at Hologic (HOLX) Raised By 3.69%

Hologic, Inc. (NASDAQ:HOLX) Logo

HSBC currently has a GBX 1870.00 target price per share on the 87.08B GBP market cap company or 14.70% upside potential. In a report issued to investors and clients on 21 June, BHP Billiton PLC (LON:BLT) stock had its Hold Rating restate by stock analysts at HSBC.

Hologic Inc (NASDAQ:HOLX) had an increase of 3.69% in short interest. HOLX’s SI was 11.91 million shares in June as released by FINRA. Its up 3.69% from 11.49 million shares previously. With 2.76M avg volume, 4 days are for Hologic Inc (NASDAQ:HOLX)’s short sellers to cover HOLX’s short positions. The SI to Hologic Inc’s float is 4.34%. It closed at $39.75 lastly. It is down 10.53% since June 21, 2017 and is downtrending. It has underperformed by 23.10% the S&P500. Some Historical HOLX News: ; 14/05/2018 – Hologic Presenting at Bank of America Conference Tomorrow; 27/03/2018 – HOLOGIC REPORTS FDA OKS 3DIMENSIONS MAMMOGRAPHY IMAGING TECH; 10/04/2018 – Hologic at Deutsche Bank Health Care Conference May 9; 27/03/2018 – Hologic Says FDA Approves New Innovations on Its 3Dimensions Mammography System; 24/04/2018 – ENZO BIOCHEM INC – PATENT TRIAL AND APPEAL BOARD HAS DENIED A PETITION FILED BY HOLOGIC FOR INTER PARTES REVIEW; 01/05/2018 – Hologic to Webcast Presentations at Upcoming Investor Conferences; 03/05/2018 – HOLOGIC GETS HEALTH CANADA AUTHORIZATION TO MARKET SCULPSURE; 02/05/2018 – HOLOGIC 2Q ADJ EPS 53C, EST. 53C; 19/04/2018 – Women Treated with Hologic’s NovaSureĀ® Endometrial Ablation System in New Study Reported Higher Amenorrhea Rates than Those Treated with Minerva; 03/05/2018 – S&PGRBulletin: Hologic Inc. Rtgs Unaffected By Write-Down

Since February 13, 2018, it had 3 insider buys, and 3 insider sales for $194,163 activity. The insider Wendell Amy McBride bought 5,200 shares worth $199,826. $389,322 worth of Hologic, Inc. (NASDAQ:HOLX) shares were sold by Valenti Peter J. III. Shares for $250,023 were bought by Nawana Namal on Tuesday, February 13. On Friday, March 16 Bebo Allison P sold $271,250 worth of Hologic, Inc. (NASDAQ:HOLX) or 7,000 shares. 13,000 shares valued at $504,400 were bought by Dockendorff Charles J on Wednesday, March 14. Oberton Karleen Marie had sold 12,196 shares worth $487,840 on Wednesday, May 2.

Among 18 analysts covering Hologic (NASDAQ:HOLX), 12 have Buy rating, 0 Sell and 6 Hold. Therefore 67% are positive. Hologic had 63 analyst reports since July 24, 2015 according to SRatingsIntel. Needham maintained Hologic, Inc. (NASDAQ:HOLX) on Friday, June 2 with “Buy” rating. The company was maintained on Thursday, August 3 by Canaccord Genuity. The company was maintained on Tuesday, January 9 by Needham. The firm has “Buy” rating by Stifel Nicolaus given on Friday, December 11. Stifel Nicolaus downgraded the stock to “Hold” rating in Friday, February 9 report. The rating was upgraded by Barclays Capital on Friday, September 23 to “Overweight”. As per Monday, October 26, the company rating was initiated by Gabelli. The rating was upgraded by BTIG Research on Monday, October 26 to “Buy”. Leerink Swann downgraded the stock to “Hold” rating in Thursday, May 3 report. The firm has “Hold” rating given on Thursday, May 3 by Deutsche Bank.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company has market cap of $10.85 billion. It operates through four divisions: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It currently has negative earnings. The Diagnostics segment provides Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, Procleix family of assays for blood screening, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test.

Investors sentiment increased to 1.03 in 2018 Q1. Its up 0.29, from 0.74 in 2017Q4. It improved, as 41 investors sold Hologic, Inc. shares while 132 reduced holdings. 58 funds opened positions while 121 raised stakes. 272.41 million shares or 3.05% more from 264.36 million shares in 2017Q4 were reported. Vident Advisory Ltd has 11,886 shares. 233,675 were reported by Chevy Chase Tru Holding. Signaturefd Limited Co holds 0% or 139 shares. Seaward Management Limited Partnership invested in 9,891 shares or 0.02% of the stock. Moneta Gru Investment Advsr Lc reported 988 shares. Moreover, Franklin Resources has 0.02% invested in Hologic, Inc. (NASDAQ:HOLX). Edge Wealth Lc holds 0% or 100 shares in its portfolio. Raymond James Trust Na owns 21,931 shares. Finemark Comml Bank reported 89,826 shares stake. Amundi Pioneer Asset accumulated 1.52 million shares. Loomis Sayles Communication Lp accumulated 0.02% or 282,580 shares. Whittier holds 231 shares or 0% of its portfolio. Sei Invests reported 152,094 shares. Bancshares Of Nova Scotia holds 0.01% or 34,910 shares in its portfolio. Axa has 2.20M shares for 0.33% of their portfolio.

Among 31 analysts covering BHP Billiton PLC (LON:BLT), 12 have Buy rating, 4 Sell and 15 Hold. Therefore 39% are positive. BHP Billiton PLC has GBX 1900 highest and GBX 515 lowest target. GBX 1269.25’s average target is -22.41% below currents GBX 1635.8 stock price. BHP Billiton PLC had 514 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Hold” rating by Deutsche Bank given on Tuesday, January 19. The rating was maintained by Credit Suisse with “Neutral” on Thursday, February 15. Deutsche Bank maintained the stock with “Buy” rating in Friday, October 13 report. The stock of BHP Billiton plc (LON:BLT) earned “Neutral” rating by Citigroup on Wednesday, August 23. On Tuesday, November 17 the stock rating was maintained by Barclays Capital with “Equal Weight”. The firm earned “Hold” rating on Thursday, May 5 by Deutsche Bank. Jefferies maintained BHP Billiton plc (LON:BLT) rating on Thursday, July 7. Jefferies has “Hold” rating and GBX 900 target. The firm has “Sector Perform” rating given on Tuesday, February 9 by RBC Capital Markets. As per Wednesday, February 24, the company rating was maintained by Deutsche Bank. On Wednesday, October 5 the stock rating was maintained by Deutsche Bank with “Hold”.

BHP Billiton Plc, together with its subsidiaries, discovers, acquires, develops, and markets natural resources worldwide. The company has market cap of 87.08 billion GBP. It operates through four divisions: Petroleum, Copper, Iron Ore, and Coal. It has a 18.57 P/E ratio. The firm explores for copper, silver, lead, zinc, molybdenum, uranium, gold, and iron ores, as well as metallurgical coal, thermal energy coal, and gas and oil properties.

Hologic, Inc. (NASDAQ:HOLX) Institutional Positions Chart